[ad_1]
The secret history of the 2018 elections in 84 color pages.
I’ll buy it
Other good news regarding vaccination: Moderna in the United States has announced that the vaccine they are developing has proven to be effective in 94.5 percent of cases. Development is still ongoing, these are only preliminary results.
The announcement came just a week after Pfizer said its vaccine promises 90% protection.
“It gives us all hope that the vaccine can stop the pandemic and bring us back to our previous lives,” Dr. Stephen Hoge, president of Moderna, told AP news agency. “Modern alone will not solve the problem. You will need many vaccines, “he added.
If the vaccine is really that effective, and this vaccine or the Pfizer vaccine gets the necessary permits, a small dose of them may be ready before the end of the year. Both vaccines must be given in two doses. 50 million Pfizer and BioNTech vaccines are expected to be manufactured by the end of the year, 20 million Moderna, but only for the US market.
The Moderna vaccine was tested on 30,000 volunteers, some of whom received a placebo. Two weeks after both doses were given, a total of 95 infections were recorded, 90 of which received placebo, not the vaccine.
Research continues and Moderna has recognized that this efficiency indicator may still change as testing progresses. It is not even known how long it will take to develop protection against the virus.
Fatigue, muscle aches, and pain around the vaccine after the second dose were mentioned as side effects of the vaccine.
[ad_2]
